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ttp://dx.doi.org/10.1016/j.ajpath.2012.10.027Mutations in the leucine-rich repeat kinase 2 (LRRK2) have been associated with familial and sporadic
cases of Parkinson disease. Mutant LRRK2 causes in vitro and in vivo neurite shortening, mediated in
part by autophagy, and a parkinsonian phenotype in transgenic mice; however, the underlying
mechanisms remain unclear. Because mitochondrial content/function is essential for dendritic
morphogenesis and maintenance, we investigated whether mutant LRRK2 affects mitochondrial
homeostasis in neurons. Mouse cortical neurons expressing either LRRK2 G2019S or R1441C mutations
exhibited autophagic degradation of mitochondria and dendrite shortening. In addition, mutant LRRK2
altered the ability of the neurons to buffer intracellular calcium levels. Either calcium chelators or
inhibitors of voltage-gated L-type calcium channels prevented mitochondrial degradation and dendrite
shortening. These data suggest that mutant LRRK2 causes a deﬁcit in calcium homeostasis, leading to
enhanced mitophagy and dendrite shortening. (Am J Pathol 2013, 182: 474e484; http://dx.doi.org/
10.1016/j.ajpath.2012.10.027)Supported by NIH grants AG026389 and NS065789 (C.T.C.). S.J.C. and
E.S. were supported in part by NIH training grants F31NS064728 and
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Current address of S.J.C., Section of Neurobiology, Division of Bio-
logical Sciences, University of California San Diego, La Jolla, California.Parkinson disease (PD) is a progressive neurodegenerative
disease that affects both subcortical and cortical brain regions,
leading to deﬁcits in motor control and cognitive decline.
Although most cases of PD are sporadic, familial mutations
account for nearly 10% of patients with PD.1 Interestingly,
mutations in the leucine-rich repeat kinase 2 (LRRK2) have
been identiﬁed in approximately 5% of familial PD cases and
1% of sporadic PD cases.2 Although the underlying patho-
genesis remains poorly understood, changes in autophagy
regulation and mitochondrial homeostasis are emerging as
common pathways in toxin and genetic models of PD.3,4
Previous studies have highlighted the importance of
mitochondrial quality control in PD models using mito-
chondrial neurotoxins or proteins encoded by recessive PD-
associated genes (Parkin, DJ-1, and PINK1) that trafﬁc to
the mitochondria.5e8 Although these mitochondrial tox-
ins and mutant proteins perturb mitochondrial respiration,stigative Pathology.
.degradation, and calcium buffering, less is known about
how nonmitochondrially targeted PD gene products, such
as LRRK2 or a-synuclein, affect mitochondrial homeo-
stasis.9e11 Recent studies suggest that autophagy regulation
may be a point of convergence among the Parkin, PINK1,
DJ-1, a-synuclein, and LRRK2 pathways.6,12e15 Autophagy
is a highly conserved, cytoplasmic recycling pathway that
engulfs proteins, aggregates, and organelles in autophago-
somes and trafﬁcs them to the lysosome for degradation.16
Autophagic turnover of mitochondria and aggregate-prone
proteins is one way to maintain healthy, functioning neurons;
LRRK2 Affects Mitochondrial Homeostasishowever, excessive degradation may have deleterious effects
leading to neurodegeneration.17 Therefore, PD-associated
genes may modulate mitochondrial homeostasis by directly
regulating mitochondrial function or by affecting mitochon-
drial degradation.4
Although LRRK2 function remains unknown, previous
studies indicate a role in regulating neurite morphological
characteristics, cytoskeletal dynamics, or the endosomal-
autophagic system.12,18e25 PD-associated mutations in the
GTPase domain (R1441C) and the kinase domain (G2019S)
have previously been shown to cause neurite shortening and
autophagy induction.12,19,22,23,25 LRRK2 may also play roles
in synaptic transmission26e28 and protein translation.29,30 A
recent study of skin ﬁbroblasts from patients bearing the
G2019S mutation showed altered mitochondrial function.31
Because LRRK2 partially associates with mitochondria18,32
and interacts with PD-associated proteins that regulate mito-
chondrial stress,33 we investigated mechanisms by which
mutations in LRRK2 affect mitochondrial homeostasis in
neurons.
Materials and Methods
All experiments were performed in accordance with research
protocols approved by the University of Pittsburgh (Pitts-
burgh, PA) Institutional Animal Care and Use Committee.
Mitochondrial Content and Dendrite Length
Measurements
Mouse E15 cortical neurons were maintained in Neurobasal,
supplementedwith 2%B27 and 2mmol/LGlutamax (all from
Invitrogen, Carlsbad, CA). The cortical neurons analyzed
were pyramidal neurons based on soma size (212  6 mm2)
and dendrite morphological characteristics.34,35 For mito-
chondrial content and dendrite length measurements, neurons
were transfected with the indicated plasmids at 7 days in vitro
(DIV). Neurons were then ﬁxed with 4% paraformaldehyde 5
days after transfection (12 DIV) for analysis of mitochondrial
content and autophagy and 14 days after transfection (21
DIV) for dendrite length. Neurons were stained with anti-
bodies to microtubule associated protein-2 (MAP2) (Milli-
pore, Billerica, MA) to identify dendrites and with anti-green
ﬂuorescent protein (GFP; Invitrogen) to identify transfected
neurons for dendrite length analysis. Axons were deﬁned as
MAP2-negative processes that exhibited known morpholog-
ical characteristics (thin and uniform diameter and length of
more than two high-power ﬁelds) that distinguish axons from
dendrites.36 ImageJ software version 1.42q (NIH) was used to
measure the mitochondrial content in primary dendrites,
axons, and soma; the primary dendrite area/neuron; and
the summated dendrite length/neuron, as illustrated in
Supplemental Figure S1.
Mitochondrial content was calculated from raw images as
follows: area of cytochrome c oxidase subunit 8 targeting
sequence (COX8)eGFPelabeled mitochondria/area for eachThe American Journal of Pathology - ajp.amjpathol.orgcompartment. For mitochondrial content and autophagy anal-
ysis, neurons were treated with 1 nmol/L baﬁlomycin A (Merck
KGaA, Darmstadt, Germany), 2 mmol/L 1,2-bis (amino-
phenoxy) ethane-N,N,N0,N0-tetraacetic acid acetoxymethyl
ester (BAPTA-AM; Invitrogen), 2 mmol/L EGTA (Sigma-
Aldrich Corp, St Louis, MO), 1 mmol/L nitrendipine (Tocris
Bioscience, Ellisville, MO), 1 mmol/L NiCl2 (Sigma-Aldrich
Corp), 50 nmol/Lu-agatoxin (Tocris Bioscience), or 100 nmol/
L w-conotoxin (Tocris Bioscience) 3 days after transfection and
analyzed 2 days later. For dendrite length analysis, neuronswere
treated as indicated at 10 days after transfection and analyzed 4
days later.
SH-SY5Y and HEK293 cells were cultured in Dulbecco’s
modiﬁed Eagle’s medium (BioWhittaker, Walkersville, MD)
with 10% fetal bovine serum (BioWhittaker), 2 mmol/L
L-glutamine (BioWhittaker), and 10 mmol/L retinoic acid
(Sigma-Aldrich Corp) for 3 days before transfection. For
neurite length, autophagosome quantiﬁcation, and mito-
chondrial content in SH-SY5Y cells, the cells were cotrans-
fected with GFP and LRRK2 [wild type (WT), mutants, or
vector] at 2 days before imaging. For BAPTA-AM treat-
ments, cells were incubated in BAPTA-AM supplemented
media for 1 day before imaging. The mitochondria were
identiﬁed in GFP-positive cells by staining for endogenous
TOM20 (Santa Cruz Biotechnology, Santa Cruz, CA).
Autophagy was inhibited using RNA interference (RNAi)
against human ATG7 (Thermo Scientiﬁc, Rockford, IL), as
previously described.12
Mitochondrial Trafﬁcking
Cortical neurons were transfected at 7 DIV and imaged at 2,
3, 4, or 5 days after transfection. Neurons were placed in
warm Dulbecco’s PBS, and mitochondrial movement in the
proximal dendrites (up to 75 mm from the soma) was imaged
every 5 seconds for a total of 5 minutes37 on a 37C
microscope stage using an inverted epiﬂuorescence micro-
scope (Olympus IX71) and Microsuite Basic Edition version
2.3 (build 1121) imaging software (Olympus America,
Center Valley, PA). The net mitochondrial movement was
tracked and quantiﬁed using ImageJ software version 1.46r
(NIH, Bethesda, MD), with the MTrackJ plug-in. Mito-
chondrial movement was deﬁned as a >2-mm change in
position within the imaging period. The percentages of
mitochondria moving in the anterograde and retrograde
directions were quantiﬁed for each neuron and expressed as
a ratio. The velocities of individual mitochondria were
quantiﬁed at 3 and 5 days after transfection.
Autophagosome Quantiﬁcation
GFPelight chain 3 (LC3)elabeled autophagosomes were
identiﬁed as bright puncta (>1.5 SDs higher than the mean
cytoplasmic ﬂuorescence), ranging from 0.5 to 1.0 mm in
diameter. The puncta were counted in each cellular compart-
ment for primary neurons.475
Cherra et alMitochondrial Polarization
Cortical neurons were transfected at 7 DIV. Neurons were
stained with 50 nmol/L tetramethylrhodamine methyl ester
(TMRM; Invitrogen) and imaged in Krebs-Ringer buffer with
12.5 nmol/L TMRM on day 3 after transfection, using
a Nikon A1 confocal microscope (Melville, NY) with <1%
laser power at 37C. TMRM equilibrates across the plasma
and mitochondrial membranes in a nernstian manner; thus,
the resulting whole cell ﬂuorescence after TMRM loading
reﬂects the potentials of both membranes.38 Mitochondrial
membrane potential (Jm) was calculated as the ratio of
mitochondrial/cytosolic TMRM staining intensity, as previ-
ously described.39 This ratio accounts for variations in
cellular polarization that affect the uptake of TMRM, thus
allowing for the comparison of ratios between mitochondrial
and cytosolic TMRM staining across multiple cells. The
staining intensity of proximal dendrites (<75 mm from the
soma) was measured in the cytosol and mitochondria using
ImageJ software. Several mitochondrial regions of interest
were selected in the dendrites of each cell and divided by
adjacent cytosolic control regions to obtain the nernstian
quotient. The average was taken as the relative mitochondrial
polarization of dendritic mitochondria.SDS-PAGE and Immunoblotting
Cortical neurons or SH-SY5Y cells were lysed in 25 mmol/L
HEPES (pH 7.5), 150 mmol/L NaCl, 5 mmol/L EDTA, 10%Figure 1 Mutant LRRK2 reduces mitochondrial content in dendrites. A: Represe
LRRK2, or vector, and COX8-GFP (green). Dendriteswere identiﬁedbyMAP2 staining (
scale. Proximal dendrites from boxes in A are presented below at a ﬁve-fold higher
responding MAP2 red channel. B: Quantiﬁcation of means SEM dendritic mitocho
neurons per group compiled from three independent experiments). C: Quantiﬁcation
three independent experiments). D and E: Quantiﬁcation of the means SEM perce
neurons per group compiled from three independent experiments). *P < 0.05 vers
476glycerol, and 1% Triton X-100. Proteins were separated by
SDS-PAGE and transferred to a polyvinylidene diﬂuoride
membrane. Blots were probed with antibodies against ATG7
(Rockland Inc.,Gilbersville, PA), glyceraldehyde-3-phosphate
dehydrogenase (Abcam, Cambridge, MA), Lamin A/C (Cell
Signaling Technology, Danvers, MA), LC3 (Nanotools,
Teningen, Germany), and LRRK2 (C41-2; Michael J. Fox
Foundation, New York City, NY).
Calcium Imaging
Cortical neurons were incubated with 5 mmol/L Fura2-AM
(Invitrogen) in normal buffer: 10 mmol/L HEPES (pH 7.6),
140mmol/LNaCl, 5mmol/LKCl, 1mmol/LCaCl2, 1mmol/L
MgCl2, and 10 mmol/L glucose at 37C for 1 hour. Cells
were washed in normal buffer for 10 minutes, and then
imaged at 25C; 50 mmol/L KCl in normal buffer was
added to determine the peak amplitude of calcium inﬂux.
Changes in cytoplasmic calcium were followed by mea-
suring the Fura2 340nm/380nm ﬂuorescence ratio in
regions of interest containing one cell. The signal deﬂec-
tion from the baseline (DF) was normalized to the mean
baseline value (F), which was established prior to stimu-
lating the cells. Calcium buffering capacity was deﬁned as
the difference in Fura2-AM intensity between peak
amplitude and the plateau phase during KCl stimulation.
To study calcium clearance, intracellular calcium was
allowed to reach the plateau phase in the presence of 50
mmol/L KCl in normal buffer; Fura2-AM intensity wasntative micrographs of cortical neurons co-expressing the indicated form of
red). For single-channelﬁgure panels, the green channelwas extracted to gray
magniﬁcation. The COX8-GFP ﬂuorescence channel is shown above the cor-
ndrial content [100 (mitochondrial pixels/dendrite pixels)] (nZ 19 to 32
ofmeans SEMdendritic area (nZ 19 to 32 neurons per group compiled from
ntage mitochondrial content in the soma and axons of neurons (nZ 14 to 32
us vector. Scale bars: 50 mm (A, upper panels); 10 mm (A, lower panels).
ajp.amjpathol.org - The American Journal of Pathology
LRRK2 Affects Mitochondrial Homeostasisthen measured on washout with normal buffer. The curve
between the Fura2-AM staining at the plateau phase with 50
mmol/L KCl and at baseline after KCl washout was ﬁt by
a mono-exponential equation, which was used to calculate
the time constant (t). In some experiments, the calcium
clearance was measured in the presence of 10 mmol/L
carbonyl cyanide 3-chlorophenylhydrazone (CCCP; Sigma-
Aldrich Corp).
Statistical Analysis
All graphical data are compiled from multiple independent
experiments. One-way analysis of variance was used to
compare the treatment groups, followed by post hoc t-tests
with Bonferroni corrections for multiple comparisons. The
sample size for all graphical data was calculated to provide
a statistical power of 0.75. A corrected P value of <0.05
was considered statistically signiﬁcant.
Results
To determinewhether LRRK2mutants affectedmitochondrial
homeostasis, we measured the percent mitochondrial content
[100  (mitochondrial area/cytoplasmic area)] in the axons,Figure 2 Mutant LRRK2 does not elicit defects in mitochondrial trafﬁcking,
movement was quantiﬁed per neuron as the ratios of mitochondria moving in the a
compiled from three independent experiments). B: The anterograde velocities of i
bars showing the means SEM (nZ 32 to 43 mitochondria per group compiled fro
mitochondria moving toward the soma are plotted, along with bars showing the m
day 5 measurements). D: Quantiﬁcation of means  SEM GFP-LC3elabeled autoph
independent experiments). E: Quantiﬁcation of means  SEM dendritic mitocho
neurons per group compiled from three independent experiments). F: Quantiﬁcatio
the presence and absence of ATG7 RNAi (n Z 26 to 58 cells per group compi
endogenous TOM20. Inset: Efﬁcacy of ATG7 knockdown. *P < 0.05 versus vector
The American Journal of Pathology - ajp.amjpathol.orgdendrites, and soma of cortical neurons co-expressing COX8-
GFP with LRRK2-WT, LRRK2-G2019S, or LRRK2-
R1441C (Figure 1A and Supplemental Figure S1). Neurons
were counterstained for MAP2 to distinguish dendrites from
axons (Figure 1A and Supplemental Figure S2A). We found
that LRRK2 PD-associated mutants, but not WT LRRK2,
caused signiﬁcant reductions in mitochondrial content in
dendrites, but not axons, at 5 days after transfection (Figure 1,
B and E, and Supplemental Figure S2A). The LRRK2-
G2019S mutant also caused a signiﬁcant decrease in
somatic mitochondrial content that was not observed with the
LRRK2-R1441C mutant (Figure 1D and Supplemental
Figure S2B), although the LRRK2 plasmids resulted in
equivalent protein expression (Supplemental Figure S2C).
There were nomorphological changes to dendrites at this time
point (Figure 1C), indicating that the decrease in mitochon-
dria density preceded subsequent reductions in dendritic area
observed at 14 days after transfection.23 The kinase-deﬁcient
LRRK2 K1906M mutant had no effect on dendritic mito-
chondrial content (Supplemental Figure S3A). Because
decreased dendritic mitochondrial content could underlie the
dendrite/neurite retraction observed in culture and mouse
models of LRRK2-related PD,19,22,23,25 we further investi-
gated causes of this decrease in mitochondrial content.but it induces autophagy to degrade mitochondria. A: Net mitochondrial
nterograde/retrograde (Ant:Ret) directions (nZ 4 to 17 neurons per group
ndividual mitochondria moving away from the soma are plotted, along with
m day 3 and day 5 measurements). C: The retrograde velocities of individual
eans  SEM (nZ 33 to 45 mitochondria per group compiled from day 3 and
agosomes per neuron (nZ 20 to 30 neurons per group compiled from three
ndrial content in the presence and absence of baﬁlomycin (n Z 5 to 32
n of means  SEM mitochondrial content in the neurites of SH-SY5Y cells in
led from three independent experiments). Mitochondria were stained for
.
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Figure 3 Mutant LRRK2 induces mitochondrial depolarization. A:
Representative micrographs of TMRM staining in the proximal dendrites of
neurons co-expressing the indicated form of LRRK2, or vector, and GFP.
Scale bar Z 20 mm. B: The means  SEM mitochondrial membrane
potential was calculated as the mean mitochondrial intensity/cytoplasmic
background in the dendritic segments analyzed (nZ 16 to 29 neurons per
group compiled from three independent experiments). C: The means  SEM
mitochondrial fraction of proximal dendrites was calculated as the area
occupied by TMRM-stained mitochondria/GFP-stained area of the proximal
dendrites (n Z 16 to 29 neurons per group compiled from three inde-
pendent experiments). *P < 0.05 versus vector.
Cherra et alMitochondrial trafﬁcking is one process that could regulate
the quantity of mitochondria by delivering or removing mito-
chondria from the dendrites. To determine whether LRRK2
mutants affected mitochondrial trafﬁcking, we measured anter-
ograde (away from the soma) and retrograde (toward the soma)
movement of COX8-GFPelabeledmitochondria in dendrites at
2 to 5 days after transfection. The percentage of mobile mito-
chondria was not signiﬁcantly changed between treatment
conditions (eg, at 5 days, vectorZ 15.64 0.42, WTZ 15.71
 0.11, G2019S Z 17.52  1.41, and R1441C Z 16.74 
1.64; PZ 0.454). The ratio of anterograde/retrograde moving
mitochondria per cell was likewise not signiﬁcantly altered
(Figure 2A). There was a trend toward a greater spread of faster-
moving anterograde mitochondria in LRRK2-transfected
neurons, but this did not result in signiﬁcant alterations in the
average anterograde (Figure 2B) or retrograde (Figure 2C)
velocities in vector versus LRRK2 (WT or mutant) expressing
neurons. Because signiﬁcant changes in mitochondrial traf-
ﬁcking were not observed, we investigated the potential role of
mitochondrial degradation.
We ﬁrst measured the levels of steady-state autophagy in
cortical neurons expressingmutant LRRK2. Themicrotubule-
associated protein LC3 is a key autophagy mediator that
covalently attaches to autophagosome membranes.40 By
using GFP fused to LC3 (GFP-LC3), we investigated whether
mutant LRRK2 altered the number of autophagosomes.
Mutant LRRK2 caused an increase in autophagosomes
compared with vector control (Figure 2D). To determine
whether autolysosomal degradation contributed to the de-
crease in dendritic mitochondria, we inhibited lysosomal
degradation with baﬁlomycin A using nontoxic doses previ-
ously shown to stabilize LC3-II from degradation,41,42 and
conﬁrmed using Western blot analysis and the tandem tfLC3
ﬂux reporter42 (Supplemental Figure S3, BeD). The inhibi-
tion of autophagic degradation prevented the loss of dendritic
mitochondria in neurons expressing mutant LRRK2
(Figure 2E). To further assess the involvement of autophagy,
SH-SY5Y cells were used because they recapitulated the
mutant LRRK2 effects observed in neurons (ie, increased
autophagosomes,12,19 neurite shortening,12,19 and the selec-
tive reduction in the mitochondrial content of neurites)
(Figure 2F), with no changes observed in the cell body for
percentage of cytoplasmic area occupied by mitochondria
(vector Z 12.50  0.54, WT Z 14.56  0.64, G2019S Z
11.31  0.64, and R1441CZ 13.45  0.83; PZ 0.10). The
inhibition of autophagy in SH-SY5Y cells usingRNAi against
ATG7, a protein essential for autophagy induction, also
reversed the effects of LRRK2 mutants on neuritic mito-
chondrial density (Figure 2F).
Because mitochondrial depolarization triggers mitochon-
drial degradation through autophagy (mitophagy) under
multiple conditions,6,43,44 we assessed whether LRRK2
mutants affected mitochondrial inner membrane polarization.
LRRK2 mutants, but not WT LRRK2, caused a signiﬁcant
decrease in dendritic mitochondrial polarization measured by
TMRM staining 3 days after transfection (Figure 3, A and B).478At this early time point, there was no change in mitochondrial
content (Figure 3C), indicating that decreases in mitochon-
drial polarization preceded the dendritic mitochondrial loss
seen after 5 days.
Calcium homeostasis is essential for both neuronal and
mitochondrial function, and aberrant elevations in intracel-
lular calcium could lead to mitochondrial and cellular
dysfunction.45 In addition to the endoplasmic reticulum,
mitochondria contribute to the maintenance of neuronal
calcium homeostasis.45,46 Because calcium metabolism and
mitochondrial function are intrinsically linked,47 we inves-
tigated whether calcium metabolism was perturbed in
neurons expressing mutant LRRK2. First, we measured the
levels of intracellular calcium with Fura2-AM in transfected
neurons after KCl stimulation. There was no difference in
the peak intracellular calcium level after stimulation;
however, there was a signiﬁcant decrease in calcium signal
recovery in neurons expressing mutant LRRK2 (Figure 4,
AeC). The calcium signal recovery is affected by calcium
channel inactivation and calcium efﬂux due to sequestration
into organelles, such as endoplasmic reticulum or mito-
chondria, and pumping across the plasma membrane. To
eliminate the channel inactivation component, we directly
measured total calcium efﬂux from the cytoplasm as the rate
of calcium signal decay after removal of KCl. The time
constant (t) of calcium efﬂux was used as a measure of its
efﬁcacy. We found that calcium efﬂux from the cytoplasm
was signiﬁcantly less efﬁcient in mutant LRRK2-expressing
neurons (Figure 4, D and E).ajp.amjpathol.org - The American Journal of Pathology
Figure 4 Mutant LRRK2 causes an imbalance in calcium homeostasis. A: A representative calcium trace illustrates the experimental paradigm and the
measures of peak amplitude and buffering capacity during KCl stimulation. B: The means  SEM peak amplitude of calcium inﬂux measured by Fura2-AM
intensity after the addition of 50 mmol/L KCl (n Z 6 to 10 neurons per group compiled from three independent experiments). C: The means  SEM buff-
ering capacity (peak amplitude  plateau intensity) measured by Fura2-AM in the presence of 50 mmol/L KCl (nZ 6 to 10 neurons per group compiled from
three independent experiments). D: Representative calcium traces illustrating calcium clearance after KCl withdrawal. Inset: Mono-exponential curve ﬁt to the
respective groups. E: Quantiﬁcation of means  SEM calcium decay time constant (t) after KCl withdrawal (n Z 11 to 17 neurons per group compiled from
three independent experiments). Max, maximum. *P < 0.05 versus vector.
LRRK2 Affects Mitochondrial HomeostasisTo determine whether the mitochondrial status was
responsible for the delayed calcium signal recovery, we
measured the t of calcium efﬂux in mutant LRRK2-
expressing neurons treated with the mitochondrial proton
uncoupler, CCCP (Figure 5, A and B). Mitochondrial
depolarization by CCCP eliminated the difference in the t
of calcium efﬂux between neurons expressing mutant
LRRK2 (relative) and either vector or WT LRRK2
(Figure 5B), implicating a role for altered mitochondrial
handling of calcium in the pathophysiological characteris-
tics of mutant LRRK2.
To determine whether calcium dysregulation contributed
to the increased turnover of mitochondria elicited by
mutant LRRK2, we measured the mitochondrial membrane
potential in neurons treated with the calcium chelator,
BAPTA-AM. Treatment with BAPTA-AM prevented
mitochondrial depolarization caused by mutant LRRK2
(Figure 5C). Furthermore, BAPTA-AM prevented eleva-
tions in autophagy and mitochondrial degradation in
neurons and SH-SY5Y cells (Figure 5, D, E, and G),
suggesting that mutant LRRK2-elicited deﬁcits in cal-
cium homeostasis led to mitochondrial depolarization and
mitophagy. Calcium chelation was also sufﬁcient to reverseThe American Journal of Pathology - ajp.amjpathol.orgthe subsequent neurite shortening elicited by mutant
LRRK2 in both neurons and SH-SY5Y cells (Figure 5, F
and H).
To identify the calcium pools involved in mutant LRRK2-
induced mitochondrial degradation, we treated neurons with
EGTA to chelate extracellular calcium. Similar to BAPTA-AM,
EGTA prevented the reduction in the percentage of dendritic
area occupied bymitochondria (vectorZ 32.87 4.57,WTZ
35.18 2.79, G2019SZ 30.55 3.12, and R1441CZ 32.14
 3.35; PZ 0.78), suggesting that extracellular calcium inﬂux
was required for mutant LRRK2-induced mitophagy in unsti-
mulated cultures. Because primary cortical neurons exhibited
spontaneous synaptic activity,48 we studied whether voltage-
gated calcium channel inhibition would prevent the calcium
inﬂuxeinduced mutant LRRK2 phenotype. There are three
families of voltage-gated calcium channels: the Cav1 (L-type),
the Cav2 (P/Q-, N-, and R-types), and the Cav3 (T-type). The L-
and T-types are primarily located in the somatodendritic
compartment, whereas the P/Q-, N-, and R-type channels are
found, to some extent, in both axonal and somatodendritic
compartments.49 T-type channels primarily facilitate small,
transient currents, whereas the other channels underlie larger
calcium ﬂuxes. Therefore, we assessed whether inhibiting479
Figure 5 Perturbed mitochondrial calcium handling is upstream of
mitochondrial depolarization, degradation, and dendrite shortening
elicited by mutant LRRK2. A: Representative calcium traces illustrating
the experimental paradigm for studying the effects of 10 mmol/L CCCP
on calcium efﬂux. B: Quantiﬁcation of the means  SEM calcium decay
time constant (t) in the presence of 10 mmol/L CCCP in normal buffer (n
Z 8 to 10 neurons per group compiled from three independent exper-
iments). C: Quantiﬁcation of means  SEM dendritic mitochondrial
membrane potential in the presence or absence of BAPTA-AM (n Z 15
to 24 neurons per group compiled from three independent experiments).
D: Quantiﬁcation of means  SEM GFP-LC3elabeled autophagosomes
per neuron in the presence or absence of BAPTA-AM (n Z 13 to 30
neurons per group compiled from three independent experiments). E:
Quantiﬁcation of means  SEM dendritic mitochondrial content in the
presence or absence of BAPTA-AM (n Z 19 to 34 neurons per group
compiled from three independent experiments). F: Quantiﬁcation of
means  SEM summated dendrite length in the presence and absence of
BAPTA-AM (n Z 10 to 35 neurons per group compiled from three
independent experiments). G: Quantiﬁcation of means  SEM neurite
autophagosomes in SH-SY5Y cells as the number of autophagosomes per
100 mm of neurite length (n Z 30 to 75 cells per group compiled from
three independent experiments). H: Quantiﬁcation of means  SEM
neurite length in SH-SY5Y cells (n Z 30 to 75 cells per group compiled
from three independent experiments). *P < 0.05 versus vector. DMSO,
dimethyl sulfoxide.
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480L-type or P/Q-, N-, andR-type channelswouldmodulatemutant
LRRK2-induced mitochondrial degradation.
We found that nitrendipine, an inhibitor of L-type
calcium channels, prevented mitochondrial degradation in
neurons expressing mutant LRRK2 (Figure 6A). However,
a mixture of NiCl2, u-agatoxin, and u-conotoxin that
inhibit N-, P/Q-, and R-type calcium channels, respectively,
was effective only in the R1441C model (Figure 6A).
Furthermore, inhibition of L-type calcium channels and, to
a lesser extent, N-, P/Q-, and R-type calcium channels
prevented dendritic shortening caused by mutant LRRK2
(Figure 6B). Together, these results suggested that altered
calcium homeostasis in mutant LRRK2-expressing neurons
contributed to mitochondrial depolarization, mitophagy, and
dendritic shortening. By normalizing the intracellular levels
of calcium via voltage-gated calcium channel inhibitors, we
prevented the mitophagy and dendritic shortening caused by
mutant LRRK2.
Discussion
Mitochondrial function is important to maintain healthy,
functioning neurons; furthermore, mitochondrial dysfunction
has been implicated in PD.3,10,50 Although data from toxin
and several recessive geneticmodels support a key pathogenic
role for mitochondrial dysfunction, the relationship of these
models to sporadic PD is complicated by differences in
pathological and clinical features. This study identiﬁes
a mechanistic link between LRRK2 mutations, which cause
late-onset PDmore closely resembling sporadic disease,51 and
mitochondrial homeostasis. Herein, we show that mutant
LRRK2 causes a deﬁcit in calcium recovery after chemical
depolarization of neurons, which would be predicted to result
in relatively sustained exposure to elevated cytosolic calcium,
contributing to mitochondrial depolarization and, ultimately,
mitochondrial degradation (Figures 2 and 3). Similar to our
ﬁndings, transgenic mice expressing the LRRK2-G2019S
mutation also show mitochondrial alterations associated with
increased autophagy.25 Furthermore, decreasedmitochondrial
function has been observed in cells derived from patients
carrying the LRRK2-G2019S mutation,31 and mitophagy is
observed in sporadic patients with PD.52 Because LRRK2
mutations are implicated in both sporadic and familial PD, and
are usually associated with classic pathological and clinical
features of PD, these data further strengthen the notion of
mitochondrial pathobiological features as an important
mechanism in PD.
In this model, mitochondrial loss, which occurs 5 days
after transfection (Figure 1), precedes dendritic shortening,
which begins 9 days after transfection23 and continues at
least another 5 days (Figures 5F and 6B). These ﬁndings are
supported by previous research showing that sufﬁcient
dendritic mitochondrial content is required for proper
dendritic morphological characteristics, neurotransmission,
and synaptic plasticity.50 A long-term reduction in mito-
chondrial content, such as in neurons expressing mutantajp.amjpathol.org - The American Journal of Pathology
Figure 6 Inhibition of L-type calcium channels prevents mutant LRRK2-
induced mitophagy and dendritic shortening. A: Quantiﬁcation of dendritic
mitochondrial content in the presence or absence of voltage-gated calcium
channel inhibitors: nitrendipine (Nit) or a mixture of NiCl2, u-agatoxin,
and u-conotoxin (Mix) (n Z 14 to 31 neurons per group compiled from
three independent experiments). B: Quantiﬁcation of total dendrite length
in the presence or absence of voltage-gated calcium channel inhibitors
(n Z 10 to 35 neurons per group compiled from three independent
experiments). Data are given as means  SEM. *P < 0.05 versus vector.
DMSO, dimethyl sulfoxide.
LRRK2 Affects Mitochondrial HomeostasisLRRK2, may further exacerbate deﬁciencies in calcium
buffering capacity, decreasing the ability to generate proper
levels of ATP and biosynthetic precursors within dendrites.
Li and colleagues53 have shown that acute decreases in
dendritic mitochondrial content rapidly lead to synapse and
spine loss after 4 days. The current study extends these
ﬁndings to show that chronic genetic stress leading to
mitochondrial degradation can also elicit more extensive
dendrite shortening after 14 days.
Both the reduction in mitochondrial content and the
subsequent reduction in dendrite length are mediated by
autophagy. We have previously shown that inhibition of
autophagy through RNAi or through phosphoregulation of
LC3 suppresses neurite shortening caused by mutant
LRRK2.12,19 However, the substrate(s) removed by auto-
phagy remained undeﬁned. The current data implicate
autophagic degradation of mitochondria as a proximal
pathogenic mechanism that underlies neurite degeneration.
Autophagy-mediated neurite shortening has also been re-
ported during axotomy, growth factor withdrawal, andThe American Journal of Pathology - ajp.amjpathol.orgneurotoxin treatment in other primary neuron and in vivo
systems.54,55 Part of the autophagy-mediated neurite short-
ening in these other models of neurodegeneration may also
be due to a mitophagy-dependent reduction in mitochondrial
support of dendrites or axons.
Because dendrites undergo large ﬂuxes in calcium, the
deﬁciencies in calcium handling could directly increase
mitochondrial stress because of their important role in
buffering excess intracellular calcium.45 Indeed, chelation of
either intracellular or extracellular calcium or inhibition of
voltage-gated calcium channels prevented mitochondrial
degradation and dendrite shortening elicited by the G2019S
or R1441C mutations in LRRK2. The observation of mito-
chondrial stress caused by LRRK2 mutants supports the
previous ﬁndings that animals expressing mutations in
LRRK2 are hypersensitive to mitochondrial toxins.56,57 This
calcium-induced mitochondrial stress could also explain
why Parkin, which plays roles in mitochondrial homeostasis
and synaptic pruning, prevents degeneration caused by
mutant LRRK2.56,58
Although this study cannot exclude a primary mito-
chondrial insult upstream of the calcium imbalance, WT
LRRK2 overexpression may regulate lysosomal calcium
mobilization in kidney cells.59 In our system, either calcium
chelation or inhibition of voltage-gated calcium channels
prevented mitochondrial degradation and neurite shortening.
Together, these data support a hypothesis by which mito-
chondrial dysfunction, elicited by mutant LRRK2, results
from calcium buffering deﬁciencies. Restoration of calcium
homeostasis using voltage-gated calcium channel inhibitors
raises an interesting therapeutic possibility, because L-type
calcium channel inhibitors also protect in toxin models of
PD.60e63 Furthermore, a tight link between voltage-gated
calcium channels and mitochondrial function has recently
been uncovered.47 The current data lend further support to
the concept that inhibition of voltage-gated calcium chan-
nels may provide a therapeutic target for familial and
sporadic PD.
Our experiments with voltage-gated calcium channel
inhibitors uncovered an interesting aspect of LRRK2 bio-
logical features. Although both the G2019S and R1441C
mutations cause calcium imbalance, mitochondrial degrada-
tion, and dendritic shortening, they have subtle differences in
their responses to calcium channel inhibitors. Inhibiting the
primarily somatodendritic L-type channels prevented mito-
chondrial degradation and neurite shortening elicited by both
mutations (Figure 6). However, inhibition of the P/Q-, N-,
and R-type channels only suppressed the effects of the
R1441C mutation (Figure 6). One possible explanation for
this discrepancy could be the degree of calcium buffering
deﬁciency in neurons expressing these mutations. The
G2019S mutation trended toward a greater decrease in
calcium signal recovery, a greater delay in calcium clearance,
and signiﬁcantly depleted mitochondria in the soma, whereas
the R1441Cmutations had milder effects on these parameters
(Figures 1D and 4, CeE). This suggests that the degree of the481
Cherra et alcalcium imbalance may govern the levels and extent of
mitochondrial injury and mitophagy.
Another explanation could be the localization of the
injury versus the localization of the calcium channels. The
L-type channels are primarily somatodendritic, but the P/Q-,
N-, and R-type channels are primarily axonal, with minor
somatodendritic localization.49 It would follow that NiCl2,
u-agatoxin, and u-conotoxin could suppress a minor deﬁcit
in calcium clearance in the somatodendritic compartment,
whereas nitrendipine is needed to suppress the greater defect
elicited by LRRK2-G2019S.
Differences in the molecular functions of LRRK2 contain-
ing thesemutations could also contribute to these observations.
Similar to the current study, the G2019S mutation produces
a more severe locomotion defect in worms than the R1441C
mutation.64 Furthermore, the R1441C mutation has less
afﬁnity for binding to LRRK2-interacting proteins when
comparedwith theG2019Smutation,65e67 suggesting possible
signaling pathway differences between the two mutants. One
underlying mechanism for these differences in signaling could
be the level of kinase activity, which is consistently higher in
theG2019S versus theR1441C.21,23,68e75 The degree of injury
and efﬁcacy of inhibitors in this study correlates with previ-
ously observed levels of kinase activity68 and the extent of
calcium imbalance. These ﬁndings indicate that, although
different mutations in LRRK2 converge in causing parkinso-
nian neurodegeneration, they may do so via distinct, as well as
converging, pathways to produce the mutant LRRK2 pheno-
types of mitochondrial loss, autophagy dysregulation, and
neurite shortening.
In conclusion, we found that mutations in LRRK2
cause calcium imbalance and mitochondrial degradation
preceding dendritic shortening. These data suggest that
excess cytosolic or mitochondrial calcium perturb mito-
chondrial homeostasis, thus playing a pathogenic role in the
mutant LRRK2 model of PD. Restoring calcium homeostasis
through calcium chelation or inhibition of voltage-gated
calcium channels was sufﬁcient to prevent the mutant
LRRK2 phenotype. Disruption of calcium homeostasis is
an early, reversible event, linking mutations in LRRK2
to mitochondrial dysfunction and neurodegeneration. Res-
toration of calcium homeostasis may provide a new thera-
peutic strategy for familial and sporadic PD.Acknowledgments
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